PubRank

A Coates

Author PubWeight™ 163.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Standardisation of spirometry. Eur Respir J 2005 48.20
2 Interpretative strategies for lung function tests. Eur Respir J 2005 21.50
3 Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000 9.70
4 General considerations for lung function testing. Eur Respir J 2005 7.99
5 Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 7.58
6 Standardisation of the measurement of lung volumes. Eur Respir J 2005 7.48
7 First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002 6.02
8 On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983 4.35
9 Energy balance and colon cancer--beyond physical activity. Cancer Res 1997 3.11
10 Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer 1998 3.03
11 A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ 2001 2.11
12 Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 2015 2.05
13 A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 1994 1.70
14 Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993 1.64
15 Specifications for equipment used for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J 2000 1.57
16 Treatment of advanced squamous cell carcinoma of head and neck with cisplatin and continuous 96 hour infusion of 5-fluorouracil. Aust N Z J Med 1989 1.38
17 Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 2009 1.35
18 The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG). Support Care Cancer 1993 1.23
19 On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol 1983 1.17
20 On the receiving end. IV: Validation of quality of life indicators. Ann Oncol 1991 1.16
21 Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect 2008 1.15
22 Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. Ann Oncol 1993 1.14
23 A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer 1995 1.11
24 Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation. Genomics 2013 1.09
25 Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care 1996 1.07
26 Measurement of respiratory system resistance by forced oscillation in normal children: a comparison with spirometric values. Pediatr Pulmonol 1991 1.05
27 Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group. Eur J Cancer 1992 1.03
28 Definition of COPD: based on evidence or opinion? Eur Respir J 2008 1.01
29 Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials. Br J Cancer 1998 0.97
30 Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group. Eur J Cancer 1998 0.94
31 Cerebral metastases from malignant melanoma. Radiother Oncol 1992 0.94
32 Promoting smoking cessation in general practice. BMJ 1993 0.94
33 Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin Exp Allergy 2004 0.90
34 Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Ann Oncol 1997 0.89
35 Aminoglutethimide in advanced prostatic carcinoma. Br J Urol 1987 0.89
36 Plant foods and colon cancer: an assessment of specific foods and their related nutrients (United States). Cancer Causes Control 1997 0.88
37 Deep Impact: observations from a worldwide Earth-based campaign. Science 2005 0.87
38 Women gain weight 1 year after smoking cessation while dietary intake temporarily increases. J Am Diet Assoc 1996 0.87
39 Chemical synthesis of 10 kDa chaperonin. Biological activity suggests chaperonins do not require other molecular chaperones. FEBS Lett 1991 0.87
40 Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates. Cancer Immunol Immunother 1987 0.87
41 Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism. Cell Immunol 1974 0.85
42 p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Ann Oncol 2008 0.85
43 Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo. Br J Psychiatry 1981 0.85
44 Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group. Ann Oncol 1994 0.84
45 Dietary energy sources and colon cancer risk. Am J Epidemiol 1997 0.84
46 Globin gene transcripts can utilize histone gene 3' end processing signals. Nucleic Acids Res 1986 0.83
47 Utomo WK, Gabbe BJ, Simpson PM, Cameron PA. Predictors of in-hospital mortality and 6-month functional outcomes in older adults after moderate to severe traumatic brain injury [Injury 2009;40(9):973-7]. Injury 2010 0.83
48 Chemotherapy for metastatic breast cancer--when is enough enough? Eur J Cancer 1997 0.82
49 Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 1993 0.81
50 Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant. Arch Dis Child 2003 0.80
51 Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma. J Interferon Res 1986 0.79
52 Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion. Cancer Chemother Pharmacol 1986 0.79
53 Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group. Eur J Cancer 1997 0.77
54 Standardisation of lung function testing: the authors' replies to readers' comments. Eur Respir J 2010 0.77
55 Immunological effects of recombinant interferon alfa-2a in patients with disseminated melanoma. Cancer 1986 0.77
56 Metabolism of pyruvate by the early human embryo. Biol Reprod 1998 0.76
57 Quality of life assessment in the International Breast Cancer Study Group: past, present, and future. Recent Results Cancer Res 1998 0.76
58 Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: still a question? Cancer Treat Rev 1998 0.76
59 Biparietal diameter at 11-13 weeks' gestation in fetuses with open spina bifida. Ultrasound Obstet Gynecol 2013 0.76
60 The quality of quality-of-life measurements. JAMA 1995 0.75
61 Who shall decide? Eur J Cancer 1995 0.75
62 Re: "Association of delayed conception with caffeine consumption". Am J Epidemiol 1994 0.75
63 What have we learned from meta-analysis? Med J Aust 1993 0.75
64 Current status of immunotherapy. Drugs 1974 0.75
65 Pulmonary pseudotumours following chemotherapy for endodermal sinus tumour of the ovary. Aust N Z J Obstet Gynaecol 1982 0.75
66 Alan Coates--CEO of the Australian Cancer Society. Interviewed by Sue Silver. Lancet Oncol 2000 0.75
67 Single-agent versus combination antiemetic treatments in patients receiving cytotoxic chemotherapy. Med J Aust 1982 0.75
68 Monitoring distributional assumptions and early stopping for a prospective clinical trial using Monte Carlo simulation. Stat Med 1987 0.75
69 Solar wind-induced atmospheric erosion at Mars: first results from ASPERA-3 on Mars Express. Science 2004 0.75
70 Information flow in the conduct of multicentred collaborative controlled clinical trials of cancer therapy. Aust N Z J Surg 1981 0.75
71 Acute leukaemia following chemotherapy including etoposide for testicular carcinoma. Aust N Z J Med 1993 0.75
72 Advanced breast cancer: response to high dose oral medroxyprogesterone acetate. Aust N Z J Med 1984 0.75
73 Sequential MTX and 5-FU: advance or myth? Eur J Cancer Clin Oncol 1986 0.75
74 Variations in sensitivity, specificity, and predictive value of a dietary fat screener modified from Block et al. J Am Diet Assoc 1995 0.75
75 Cyclophosphamide in pregnancy. Aust N Z J Obstet Gynaecol 1970 0.75
76 Chemotherapy for head and neck cancer. Med J Aust 1983 0.75
77 Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer. Cancer Treat Rep 1987 0.75
78 Growth hormone response in very short children. Clin Invest Med 1991 0.75
79 Chemotherapy of advanced colorectal cancer. A randomized trial of sequential methotrexate and 5-fluorouracil. Am J Clin Oncol 1987 0.75
80 Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma. J Biol Response Mod 1986 0.75
81 Controversies in pediatric pulmonary medicine: infant pulmonary function tests. Am Rev Respir Dis 1988 0.75
82 Mars environment and magnetic orbiter scientific and measurement objectives. Astrobiology 2009 0.75
83 Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy. Aust N Z J Med 1983 0.75
84 Hymenolepis diminuta: active transport of alpha-aminoisobutyric acid by cysticercoid larvae. Int J Parasitol 1973 0.75
85 Benzo[a]pyrene site of contact mutagenicity in skin of Muta Mouse. Mutagenesis 1998 0.75
86 The use of L-dopa and carbidopa in metastatic malignant melanoma. J Invest Dermatol 1991 0.75
87 BCG immunotherapy. Med J Aust 1977 0.75
88 Leslie Everton Hurley. Med J Aust 1967 0.75
89 Phase I study of epirubicin given on a weekly schedule. Cancer Treat Rep 1987 0.75
90 Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean). Ann Oncol 2004 0.75
91 Current status of chemotherapy of breast cancer. Drugs 1984 0.75